Vident Advisory’s Genpact G Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$891K Buy
32,382
+4,710
+17% +$155K 0.01% 1042
2026
Q1
$1.03M Buy
27,672
+22,972
+489% +$946K 0.01% 862
2025
Q4
$220K Sell
4,700
-17,732
-79% -$767K ﹤0.01% 1513
2025
Q3
$940K Buy
22,432
+17,530
+358% +$771K 0.01% 858
2025
Q2
$216K Buy
+4,902
New +$222K ﹤0.01% 1471
2025
Q1
– Sell
-17,215
Closed -$739K – 1580
2024
Q4
$739K Sell
17,215
-2,200
-11% -$92.8K 0.01% 772
2024
Q3
$761K Buy
+19,415
New +$702K 0.02% 733
2024
Q2
– Sell
-9,428
Closed -$311K – 1447
2024
Q1
$311K Buy
9,428
+1,975
+26% +$68.6K 0.01% 1007
2023
Q4
$259K Buy
7,453
+1,755
+31% +$60.5K 0.01% 1072
2023
Q3
$206K Buy
+5,698
New +$212K 0.01% 1099

Other funds holding G

Vident Advisory's G Position: Q2 2026 in Review

Vident Advisory increased its Genpact (G) stake by 17% in Q2 2026, buying an estimated $155K and bringing the position to 32,382 shares worth $891K. The position accounts for 0.01% of the portfolio, ranked #1042.

Vident Advisory first reported a position in G in Q3 2023 and has held it in 10 quarters since. The position peaked at $1.03M in Q1 2026. 479 funds tracked by Wall St. Rank hold G as of Q2 2026.

  • Vident Advisory held 32,382 shares of Genpact worth $891K as of Q2 2026.
  • Vident Advisory bought 4,710 Genpact shares in Q2 2026, an estimated $155K.
  • Genpact made up 0.01% of Vident Advisory's portfolio in Q2 2026, its #1042 holding.
  • Vident Advisory first reported a position in Genpact in Q3 2023 and has held it in 10 quarters since.
  • Vident Advisory's Genpact position peaked at $1.03M in Q1 2026.
  • 479 funds tracked by Wall St. Rank held Genpact as of Q2 2026.

Based on Vident Advisory's 13F filing for Q2 2026, filed 12 Aug 2026.